HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoxi Lin Selected Research

Dye Lasers

1/2022Can 595-nm Pulsed Dye Laser in Conjunction With an Optical Clearing Agent Improve the Treatment of Port-Wine Stains?
7/2021Blood Perfusion May Determine the Therapeutic Effect of Pulsed Dye Laser on Port-Wine Stains Located on Extremities.
1/2021Combination Therapy of Pulsed Dye Laser With Intense Pulsed Light in Port-Wine Stain Treatment: A Prospective Side-by-Side Comparison.
4/2020Retrospective study of photodynamic therapy for pulsed dye laser-resistant port-wine stains.
1/2020Assessment of Outcomes With Pulsed Dye Laser Treatment of Port-Wine Stains Located Proximally vs Distally on Extremities.
3/2019Port-wine stains on the neck respond better to a pulsed dye laser than lesions on the face: An intrapatient comparison study with histopathology.
11/2018Less is more: similar efficacy in three sessions and seven sessions of pulsed dye laser treatment in infantile port-wine stain patients.
6/2018Double Pass 595 nm Pulsed Dye Laser Does Not Enhance the Efficacy of Port Wine Stains Compared with Single Pass: A Randomized Comparison with Histological Examination.
4/2018EMLA cream does not influence efficacy and pain reduction during pulsed-dye laser treatment of port-wine stain: a prospective side-by-side comparison.
1/2018Shorter Treatment Intervals of East Asians with Port-Wine Stain with Pulsed Dye Laser Are Safe and Effective-A Prospective Side-by-Side Comparison.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoxi Lin Research Topics

Disease

23Hemangioma (Angioma)
01/2022 - 03/2002
18Port-Wine Stain (Nevus Flammeus)
03/2022 - 03/2015
6Cicatrix (Scar)
12/2022 - 11/2009
4Arteriovenous Malformations (Arteriovenous Malformation)
07/2022 - 01/2018
4Hyperpigmentation
05/2022 - 03/2015
4Pain (Aches)
03/2022 - 03/2017
4Congenital Abnormalities (Deformity)
01/2022 - 10/2019
3Vascular Malformations
03/2015 - 03/2002
2Acne Vulgaris
05/2022 - 11/2009
2Erythema
05/2022 - 03/2015
2Neoplasms (Cancer)
01/2022 - 02/2016
2Melanoma (Melanoma, Malignant)
12/2021 - 08/2020
2Paralysis (Palsy)
01/2021 - 06/2008
2Hemorrhage
01/2021 - 03/2017
2Infections
01/2019 - 01/2018
2Fever (Fevers)
03/2015 - 06/2008
1Inflammation (Inflammations)
12/2022
1Reperfusion Injury
12/2022
1Acute Kidney Injury (Acute Renal Failure)
12/2022
1Neurofibroma
07/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Circulating Neoplastic Cells
01/2022
1Hypertrophy
09/2021
1Hypesthesia (Numbness)
01/2021
1Diplopia (Double Vision)
01/2021
1Ectropion
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Eye Infections
01/2021
1Open Bite (Openbite)
03/2020
1Macroglossia
03/2020
1Bone Resorption
12/2019
1Pigmented Nevus (Melanocytic Nevus)
10/2019
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2019
1Nevus of Ota
09/2018
1Body Weight (Weight, Body)
04/2018
1Surgical Wound
01/2018
1Tachypnea
01/2018
1Hemangioendothelioma
01/2018
1Virus Diseases (Viral Diseases)
01/2018

Drug/Important Bio-Agent (IBA)

10Propranolol (Inderal)FDA LinkGeneric
01/2022 - 02/2014
41-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2022 - 03/2015
3bleomycetinIBA
01/2022 - 06/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2002
3hematoporphyrin monomethyl etherIBA
04/2020 - 01/2016
3PlasticsIBA
01/2020 - 06/2017
3CytokinesIBA
01/2019 - 03/2002
3Bleomycin (Blenoxane)FDA LinkGeneric
04/2018 - 03/2015
3Timolol (Blocadren)FDA LinkGeneric
06/2017 - 05/2014
2Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2022
2Botulinum Toxins (Botulinum Toxin)IBA
01/2019 - 01/2018
2Anesthetics (Anesthetic Agents)IBA
04/2018 - 03/2017
2MicroRNAs (MicroRNA)IBA
01/2018 - 02/2016
2Ethanol (Ethyl Alcohol)IBA
01/2018 - 06/2008
2Pharmaceutical PreparationsIBA
03/2015 - 05/2014
2Imiquimod (Aldara)FDA LinkGeneric
05/2013 - 05/2011
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2005 - 03/2002
2ImmunosorbentsIBA
07/2005 - 03/2002
2EnzymesIBA
07/2005 - 03/2002
1Tissue Adhesives (Tissue Adhesive)IBA
12/2022
1Hyaluronic Acid (Hyaluronan)IBA
12/2021
1NanogelsIBA
12/2021
1Liposomes (Liposome)IBA
12/2021
1Melanins (Melanin)IBA
12/2021
1Tranexamic Acid (AMCA)FDA Link
12/2021
1Monophenol Monooxygenase (Tyrosinase)IBA
12/2021
1Therapeutic UsesIBA
07/2021
1cobaltous chloride (cobalt(II)chloride)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2020
1photocarcinorinIBA
06/2019
1Photosensitizing Agents (Photosensitizers)IBA
06/2019
1InterferonsIBA
01/2019
1Pattern Recognition ReceptorsIBA
01/2019
1alexandriteIBA
09/2018
1Prilocaine Drug Combination LidocaineFDA LinkGeneric
04/2018
1Proteins (Proteins, Gene)FDA Link
01/2018

Therapy/Procedure

13Dye Lasers
01/2022 - 03/2016
8Therapeutics
07/2022 - 07/2005
7Lasers (Laser)
07/2022 - 11/2009
6Photochemotherapy (Photodynamic Therapy)
03/2022 - 03/2015
5Injections
01/2022 - 03/2015
3Laser Therapy (Surgery, Laser)
09/2021 - 03/2015
3Blepharoplasty
10/2019 - 01/2017
2Sclerotherapy
03/2022 - 03/2020
2Tissue Expansion Devices (Tissue Expander)
01/2020 - 12/2019
2Solid-State Lasers
09/2018 - 05/2014
2Anesthesia
04/2018 - 03/2017
2Rhinoplasty
01/2018 - 06/2017
1Ischemic Postconditioning
12/2022
1Combined Modality Therapy
07/2022
1Intense Pulsed Light Therapy
05/2022
1Rhytidoplasty (Facelift)
09/2021
1Lipectomy (Liposuction)
08/2021
1Telescopes
01/2021
1Osteotomy
03/2020
1Orthognathic Surgery
03/2020
1Tissue Expansion
12/2019
1Rejuvenation
10/2019
1Operative Surgical Procedures
05/2019